Targeting hyaluronan (HA) in tumor stroma: Interim safety and translational evaluation of pegylated hyaluronidase (PEGPH20) in patients (pts) with advanced solid tumors—A focus on gastrointestinal malignancies.
Jeffrey R. Infante
Consultant or Advisory Role - Halozyme Therapeutics
Ramesh K. Ramanathan
Consultant or Advisory Role - Halozyme Therapeutics
Mitesh J. Borad
Consultant or Advisory Role - Halozyme Therapeutics
Lee S. Rosen
No relevant relationships to disclose
Ronald Korn
Consultant or Advisory Role - Halozyme Therapeutics
Samuel Simon Dychter
Employment or Leadership Position - Halozyme Therapeutics
Stock Ownership - Halozyme Therapeutics
Harold Michael Shepard
Employment or Leadership Position - Halozyme Therapeutics
Stock Ownership - Halozyme Therapeutics
Daniel C. Maneval
Employment or Leadership Position - Halozyme Therapeutics
Stock Ownership - Halozyme Therapeutics
Ping Jiang
Employment or Leadership Position - Halozyme Therapeutics
Stock Ownership - Halozyme Therapeutics
Deborah Carson
Employment or Leadership Position - Halozyme Therapeutics
Stock Ownership - Halozyme Therapeutics
Daniel D. Von Hoff
Consultant or Advisory Role - Halozyme Therapeutics
Gregory Ian Frost
Employment or Leadership Position - Halozyme Therapeutics
Stock Ownership - Halozyme Therapeutics